registration will start in October – El Financiero

• Immunosuppression.
• Severe chronic lung disease.
• Chronic affections of the kidney, liver or digestive system.
• Chronic neurological disease.
• Cardiovascular diseases.
• Diabetes and other endocrine diseases.
• Genetic or chromosomal abnormalities.
• Teen pregnancy.

At the moment, the only vaccine that can be applied to the sector of this population is that of the pharmaceutical Pfizer-BioNTech, since it is the only one that has been shown to be effective in this vulnerable group.

The Undersecretary of Health indicated that adolescent pregnancy is a public health problem in itself.

In the operational strategy for this phase of the National Vaccination Program, the technical guideline and list of comorbidities will be published on September 28.

In addition, the first week of October the immunization units will be ready.

Unlike the first stages of inoculation, in which temporary vaccinating cells were established according to the territory, for this sector of the population each health institution will identify the population at risk and establish permanent stations.

“Given the relatively limited universe in number, we are going to follow a procedure that is different from the general vaccination of adults. (…) in this case, how the vast majority or practically all are necessarily identified, because otherwise they could not have a healthy life as long as diseases are controlled, we are going to use the infrastructure of the national health system. That is to say, in the medical units where these people are treated ”, said López-Gatell.